| Mammalian reverse genetics without crossing reveals Nr3a as a short-sleeper gene GA Sunagawa, K Sumiyama, M Ukai-Tadenuma, D Perrin, H Fujishima, ... Cell reports 14 (3), 662-677, 2016 | 114 | 2016 |
| A strategy for large-scale phosphoproteomics and SRM-based validation of human breast cancer tissue samples R Narumi, T Murakami, T Kuga, J Adachi, T Shiromizu, S Muraoka, ... Journal of proteome research 11 (11), 5311-5322, 2012 | 110 | 2012 |
| Discovery of colorectal cancer biomarker candidates by membrane proteomic analysis and subsequent verification using selected reaction monitoring (SRM) and tissue microarray … H Kume, S Muraoka, T Kuga, J Adachi, R Narumi, S Watanabe, ... Molecular & Cellular Proteomics 13 (6), 1471-1484, 2014 | 88 | 2014 |
| Mass spectrometry-based absolute quantification reveals rhythmic variation of mouse circadian clock proteins R Narumi, Y Shimizu, M Ukai-Tadenuma, KL Ode, GN Kanda, ... Proceedings of the National Academy of Sciences 113 (24), E3461-E3467, 2016 | 81 | 2016 |
| Knockout-rescue embryonic stem cell-derived mouse reveals circadian-period control by quality and quantity of CRY1 KL Ode, H Ukai, EA Susaki, R Narumi, K Matsumoto, J Hara, N Koide, ... Molecular cell 65 (1), 176-190, 2017 | 73 | 2017 |
| Proteomic analysis of urinary and tissue‐exudative extracellular vesicles to discover novel bladder cancer biomarkers E Tomiyama, K Matsuzaki, K Fujita, T Shiromizu, R Narumi, K Jingushi, ... Cancer Science 112 (5), 2033-2045, 2021 | 43 | 2021 |
| The role of actinin-4 (ACTN4) in exosomes as a potential novel therapeutic target in castration-resistant prostate cancer Y Ishizuya, M Uemura, R Narumi, E Tomiyama, Y Koh, M Matsushita, ... Biochemical and Biophysical Research Communications 523 (3), 588-594, 2020 | 35 | 2020 |
| Establishment of TSH β real‐time monitoring system in mammalian photoperiodism K Tsujino, R Narumi, K Masumoto, EA Susaki, Y Shinohara, T Abe, M Iigo, ... Genes to Cells 18 (7), 575-588, 2013 | 23 | 2013 |
| Cell-free synthesis of stable isotope-labeled internal standards for targeted quantitative proteomics R Narumi, K Masuda, T Tomonaga, J Adachi, HR Ueda, Y Shimizu Synthetic and Systems Biotechnology 3 (2), 97-104, 2018 | 22 | 2018 |
| Proteomics of serum extracellular vesicles identifies a novel COPD biomarker, fibulin-3 from elastic fibres T Koba, Y Takeda, R Narumi, T Shiromizu, Y Nojima, M Ito, M Kuroyama, ... ERJ Open Research 7 (1), 2021 | 19 | 2021 |
| Hepatitis C virus enhances Rubicon expression, leading to autophagy inhibition and intracellular innate immune activation Y Shiode, H Hikita, S Tanaka, K Shirai, A Doi, S Sakane, Y Kai, ... Scientific reports 10 (1), 15290, 2020 | 16 | 2020 |
| Adenovirus vector-based incorporation of a photo-cross-linkable amino acid into proteins in human primary cells and cancerous cell lines A Kita, N Hino, S Higashi, K Hirota, R Narumi, J Adachi, K Takafuji, ... Scientific Reports 6 (1), 36946, 2016 | 15 | 2016 |
| Targeted phosphoproteome analysis using selected/multiple reaction monitoring (SRM/MRM) J Adachi, R Narumi, T Tomonaga Proteomics in Systems Biology: Methods and Protocols, 87-100, 2016 | 12 | 2016 |
| EphA2 on urinary extracellular vesicles as a novel biomarker for bladder cancer diagnosis and its effect on the invasiveness of bladder cancer E Tomiyama, K Fujita, K Matsuzaki, R Narumi, A Yamamoto, T Uemura, ... British Journal of Cancer 127 (7), 1312-1323, 2022 | 10 | 2022 |
| Quantitative analysis of tissue samples by combining iTRAQ isobaric labeling with selected/multiple reaction monitoring (SRM/MRM) R Narumi, T Tomonaga Phospho-Proteomics: Methods and Protocols, 85-101, 2016 | 9 | 2016 |
| Identification of CD14 and lipopolysaccharide-binding protein as novel biomarkers for sarcoidosis using proteomics of serum extracellular vesicles Y Futami, Y Takeda, T Koba, R Narumi, Y Nojima, M Ito, M Nakayama, ... International Immunology 34 (6), 327-340, 2022 | 8 | 2022 |
| Substrate-induced conformational changes in sarcoplasmic reticulum Ca2+-ATPase probed by surface modification using diethylpyrocarbonate with mass spectrometry R Narumi, T Yamamoto, A Inoue, T Arata FEBS letters 586 (19), 3172-3178, 2012 | 7 | 2012 |
| A large‐scale targeted proteomics of plasma extracellular vesicles shows utility for prognosis prediction subtyping in colorectal cancer K Kasahara, R Narumi, S Nagayama, K Masuda, T Esaki, K Obama, ... Cancer Medicine 12 (6), 7616-7626, 2023 | 6 | 2023 |
| Serum amyloid P component and pro-platelet basic protein in extracellular vesicles or serum are novel markers of liver fibrosis in chronic hepatitis C patients K Shirai, H Hikita, S Sakane, R Narumi, J Adachi, A Doi, S Tanaka, ... Plos one 17 (7), e0271020, 2022 | 5 | 2022 |
| GSK3 inhibition circumvents and overcomes acquired lorlatinib resistance in ALK-rearranged non-small-cell lung cancer Y Shimizu, K Okada, J Adachi, Y Abe, R Narumi, K Uchibori, N Yanagitani, ... NPJ Precision Oncology 6 (1), 16, 2022 | 5 | 2022 |
